InvestorsHub Logo
Followers 27
Posts 3416
Boards Moderated 0
Alias Born 07/17/2006

Re: None

Monday, 12/26/2016 2:39:34 AM

Monday, December 26, 2016 2:39:34 AM

Post# of 345997
After the disaster of the Sunrise trial, Peregrine has moved forward with solid Avid growth and prudent efforts to salvage Bavi as part of the immunotherapy approach to cancer.

Spin it any way you like, Peregrine's much-maligned management clearly has a vision that could succeed. I hope 2017 will finally be the year we stop regretting our investment in Peregrine.

Ho, Ho, Ho, Paul
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News